Cross-sectional study shows high non-compliance rates in schizophrenia patients, indicating key factors like marital status and follow-up visits.
Abstract Introduction: Medication Compliance is the cornerstone for the treatment or prevention of relapse in schizophrenia. This study focuses on assessing the frequency and factors that affect medication non-compliance in patients with schizophrenia in Peshawar. Methods: We conducted this cross-sectional study in a psychiatrist clinic in Peshawar between November 2022 and May 2023. The data of 146 patients with schizophrenia patients, was collected by a pre-tested questionnaire. Descriptive statistics were applied to determine frequency and a chi-square test was used to determine the association between factors affecting medication non-compliance. Results: Out of 146 participants in our study, 115 (78.8%) patients with schizophrenia were found to be non-compliant with their medication regimen. Marital status was a key factor with 84.4% of married patients being non-compliant (p = 0.022). Follow-up visits with prescribing physicians showed significant results with 98.1% of patients who did not follow up being non-compliant (p = 0.00). Key factors associated with medication non-compliance included good response to treatment (57.4%), medication cost (48.7%), and lack of proper counseling on medication usage by physicians (73.9%). Conclusions: Our study concludes that medication non-compliance in patients with schizophrenia patients is a significant challenge in KPK province of Pakistan. Being married, not following up with a prescribing physician, good response to treatment, medication cost, unavailability of medication in the market and lack of proper counseling about medication use were the key factors highlighted in our study.
No takes yet. Share an insight, caveat, or question.
Dur-e-Nayab et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: